ipilimumab
ipilimumab
- CAS:
- 477202-00-9
- MF:
- MW:
- 0
Suppliers by country/region
Properties
- form
- Liquid
- color
- Colorless to light yellow
Safety Information
Use
Ipilimumab is a CTLA-4 blocking antibody that was approved by the U.S. FDA in March 2011 for the treatment of unresectable or metastatic melanoma. Therefore, ipilimumab has an indirect effect on tumors that is mediated through blockade of CTLA-4 negative signaling and augmentation of T-cell activity. It is one of a handful of immunostimulatory drugs (e.g., aldesleukin and interferon alfa-2b) now approved for cancer therapy.
0 India supplier list of "ipilimumab"
- Product Name:ipilimumab
- Products Intro:Purity: 99% | Package: 1g;USD|10g;USD|100g;USD
- Company Type: Trader
- Country/Region: CHINA
- Main Products: Linoleic Acid,Vitamin B12,Riboflavin,β-Nicotinamide Mononucleotide,Amoxicillin trihydrate
- Product Name:ipilimumab
- Products Intro:Purity: 98% | Package: 10g
- Company Type: Trader
- Country/Region: CHINA
- Main Products: SARMS,Peptides,Nootropics,Pre-workouts,Nutrition supplements
$0.00/ 10g